Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and first half (H1) of the fiscal year ... Read More
Piramal Pharma Solutions bets big on injectables market with $80m expansion—Lexington site to double output by 2027
Piramal Pharma Solutions has announced an unprecedented $80 million expansion of its sterile injectables facility in Lexington, Kentucky. The company’s aggressive move aims to address ... Read More
Piramal Pharma Solutions unveils expanded ADC facility in Scotland amid growing market demand
Piramal Pharma Solutions (PPS), a prominent Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (PPL) has opened its expanded antibody-drug conjugate ... Read More